Acquired haemophilia as a complicating factor in treatment of non-muscle invasive bladder cancer: A case report

Table 2 Comparison of the present case to previously reported cases of acquired haemophilia associated with bladder cancer

Parameter (physiological range)	Case 1[3]	Case 2[2]	Case 3[11]	Presented case
	Bladder cancer. Sepsis. Rectal cancer	Bladder cancer. Sepsis	Bladder cancer. Lung mass. Lupus anticoagulant	Bladder cancer
FVIII (50%-150%)	≤ 1%	1%		2%
Inhibitor FVIII (0.0-0.8 BU/L)	64 BU/L	57 BU/L	250 BU/L	33 BU/L
Bleeding symptoms	Hematothorax. Subcutaneous haematoma	Intramuscular haematoma. Subcutaneous haematoma	Intramuscular haematoma. Subcutaneous haematoma	Haematuria
Therapy	Cyclophosphamide and prednisone	Cyclophosphamide and prednisone. Rituximab	Cyclophosphamide and prednisone. Rituximab	Cyclophosphamide and prednisone. Rituximab